Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2016 2
2018 2
2019 7
2020 8
2021 2
2022 7
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy.
Michel L, Helfrich I, Hendgen-Cotta UB, Mincu RI, Korste S, Mrotzek SM, Spomer A, Odersky A, Rischpler C, Herrmann K, Umutlu L, Coman C, Ahrends R, Sickmann A, Löffek S, Livingstone E, Ugurel S, Zimmer L, Gunzer M, Schadendorf D, Totzeck M, Rassaf T. Michel L, et al. Eur Heart J. 2022 Jan 31;43(4):316-329. doi: 10.1093/eurheartj/ehab430. Eur Heart J. 2022. PMID: 34389849
[Drug-induced cardiomyopathies].
Michel L, Rassaf T. Michel L, et al. Dtsch Med Wochenschr. 2022 Nov;147(23):1513-1522. doi: 10.1055/a-1810-9275. Epub 2022 Nov 16. Dtsch Med Wochenschr. 2022. PMID: 36384152 German.
Cardio-oncology: need for novel structures.
Michel L, Rassaf T. Michel L, et al. Eur J Med Res. 2019 Jan 3;24(1):1. doi: 10.1186/s40001-018-0359-0. Eur J Med Res. 2019. PMID: 30606260 Free PMC article.
Cardiotoxicity from immune checkpoint inhibitors.
Michel L, Rassaf T, Totzeck M. Michel L, et al. Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. eCollection 2019 Dec. Int J Cardiol Heart Vasc. 2019. PMID: 31517036 Free PMC article. Review.
Oncocardiology: new challenges, new opportunities.
Michel L, Schadendorf D, Rassaf T. Michel L, et al. Herz. 2020 Nov;45(7):619-625. doi: 10.1007/s00059-020-04951-x. Herz. 2020. PMID: 32514587 Free PMC article. Review.
[Heart and cancer: cardio-oncology].
Michel L, Rassaf T. Michel L, et al. Herz. 2024 Mar;49(2):111-117. doi: 10.1007/s00059-024-05232-7. Epub 2024 Jan 30. Herz. 2024. PMID: 38289420 Review. German.
[Cardiovascular complications from cancer therapy].
Michel L, Rassaf T. Michel L, et al. MMW Fortschr Med. 2022 Feb;164(2):48-56. doi: 10.1007/s15006-021-0589-x. MMW Fortschr Med. 2022. PMID: 35088334 German. No abstract available.
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart.
Korste S, Settelmeier S, Michel L, Odersky A, Stock P, Reyes F, Haj-Yehia E, Anker MS, Grüneboom A, Hendgen-Cotta UB, Rassaf T, Totzeck M. Korste S, et al. Among authors: michel l. Int J Mol Sci. 2023 Mar 23;24(7):6052. doi: 10.3390/ijms24076052. Int J Mol Sci. 2023. PMID: 37047026 Free PMC article.
33 results